<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00919230</url>
  </required_header>
  <id_info>
    <org_study_id>R&amp;D/2003/21</org_study_id>
    <nct_id>NCT00919230</nct_id>
  </id_info>
  <brief_title>Randomised Trial Comparing Iron Supplementation Versus Placebo in the Treatment of Anaemia After Hip Fracture</brief_title>
  <official_title>Randomised Trial Comparing Iron Supplementation Versus Placebo in the Treatment of Anaemia After Hip Fracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peterborough and Stamford Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peterborough Hospitals Hip Fracture Project</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peterborough and Stamford Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      At present our current practice is to provide a course of oral iron therapy for those
      patients with a post-operative haemoglobin which is below normal, but not severe enough to
      require a blood transfusion. Such a practice is not without side effects from the iron
      tablets, namely ingestion, nausea, diarrhoea, constipation. There is little evidence in the
      literature to support the current practice of using iron, with only one small randomised
      trial suggesting such therapy is unnecessary. We propose to recruit 300 patients recovering
      from a hip fracture with a post-operative haemoglobin below 11g/l. For those patients willing
      to enter the study, half will be given oral iron therapy (ferrous sulphate 200mg twice daily)
      for one month. The haemoglobin will be checked when the patients attends the hip fracture
      clinic at 6 weeks after discharge.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 week hemoglobin</measure>
    <time_frame>6 weeks after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay side effects of therapy mortality</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Hip Fracture</condition>
  <arm_group>
    <arm_group_label>no treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no iron given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ferrous sulphate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>iron given</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferrous sulphate tablets</intervention_name>
    <description>200mg twice daily for four weeks</description>
    <arm_group_label>ferrous sulphate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with anaemia after surgery for a hip fracture

        Exclusion Criteria:

          -  absence of anaemia, inability to provide consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martyn Parker</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peterborough Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peterborough city hospital</name>
      <address>
        <city>Peterborough</city>
        <state>Cambs</state>
        <zip>pe67nj</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Parker MJ. Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. J Bone Joint Surg Am. 2010 Feb;92(2):265-9. doi: 10.2106/JBJS.I.00883.</citation>
    <PMID>20124051</PMID>
  </reference>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2009</study_first_submitted>
  <study_first_submitted_qc>June 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2009</study_first_posted>
  <last_update_submitted>December 7, 2012</last_update_submitted>
  <last_update_submitted_qc>December 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peterborough and Stamford Hospitals NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Martyn J Parker</investigator_full_name>
    <investigator_title>research fellow</investigator_title>
  </responsible_party>
  <keyword>Hip fracture</keyword>
  <keyword>iron therapy</keyword>
  <keyword>anaemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>June 2, 2017</submitted>
    <returned>November 2, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

